Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
Review paper
Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
Małgorzata Pawłowska,
Robert Flisiak,
Lidia Gil,
Andrzej Horban,
Iwona Hus,
Jerzy Jaroszewicz,
Ewa Lech-Marańda,
Jan Styczyński
Clin Exp HEPATOL 2019; 5, 3:195–202
Online publish date: 2019-09-05
Review paper
Hepatobiliary manifestations of inflammatory bowel disease in children
Magdalena Kucharska,
Urszula Daniluk,
Kamila Agnieszka Kwiatek-Średzińska,
Natalia Wasilewska,
Aleksandra Filimoniuk,
Piotr Jakimiec,
Katarzyna Zdanowicz,
Dariusz Marek Lebensztejn
Clin Exp HEPATOL 2019; 5, 3: 203–209
Online publish date: 2019-09-05
Original paper
Perspectives of hepatitis C virus (HCV) elimination in Poland
Robert Flisiak,
Dorota Zarębska-Michaluk
Clin Exp HEPATOL 2019; 5, 3: 210–214
Online publish date: 2019-09-05
Original paper
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study
Krzysztof Adam Simon,
Robert Flisiak,
Tadeusz Wojciech Łapiński,
Ewa Janczewska,
Marta Wawrzynowicz-Syczewska,
Jerzy Jaroszewicz,
Dorota Zarębska-Michaluk,
Khalil Nazzal,
Beata Bolewska,
Jolanta Białkowska,
Hanna Berak,
Katarzyna Fleischer-Stępniewska,
Krzysztof Tomasiewicz,
Kornelia Karwowska,
Karolina Anna Rostkowska,
Anna Piekarska,
Olga Tronina,
Grzegorz Madej,
Aleksander Garlicki,
Mariusz Łucejko,
Arkadiusz Pisula,
Ewa Karpińska,
Wiesław Kryczka,
Alicja Wiercińska-Drapało,
Iwona Mozer-Lisewska,
Maciej Stanisław Jabłkowski,
Andrzej Horban,
Brygida Knysz,
Magdalena Tudrujek,
Waldemar Halota
Clin Exp HEPATOL 2019; 5, 3: 215–223
Online publish date: 2019-09-05
Original paper
Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study
Elaheh Zarean,
Reza Goujani,
Ghorbanali Rahimian,
Ali Ahamdi
Clin Exp HEPATOL 2019; 5, 3: 224–231
Online publish date: 2019-09-05
Original paper
Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of Poland
Robert Pleśniak,
Marta Wawrzynowicz-Syczewska
Clin Exp HEPATOL 2019; 5, 3: 232–236
Online publish date: 2019-09-05
Original paper
Acute effects of different doses of malathion on the rat liver
Çınar Severcan,
Murat Ekremoglu,
Bayram Sen,
Ozge Tugce Pasaoglu,
Nalan Akyurek,
Suzan Muratoglu Severcan,
Hatice Pasaoglu
Clin Exp HEPATOL 2019; 5, 3: 237–243
Online publish date: 2019-09-05
Original paper
Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis
Nadim Mahmud,
Sahil D. Doshi,
Kimberly A. Forde,
Vandana Khungar
Clin Exp HEPATOL 2019; 5, 3: 244–249
Online publish date: 2019-09-05
Original paper
Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct
Vor Luvira,
Supot Kamsa-ard,
Ake Pugkhem,
Varisara Luvira,
Tharatip Srisuk,
Attapol Titapun,
Artit Silsirivanit,
Sopit Wongkham,
Narong Khuntikeo,
Chawalit Pairojkul,
Vajarabhongsa Bhudhisawasdi
Clin Exp HEPATOL 2019; 5, 3: 250–255
Online publish date: 2019-09-05
Original paper
Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response
Hala A. Agina,
Nermine A. Ehsan,
Taghreed A. Abd-Elaziz,
Ghada A. Abd-Elfatah,
Eman M. Said,
Mostafa M. Sira
Clin Exp HEPATOL 2019; 5, 3: 256–264
Online publish date: 2019-09-05
|